RASAL2-AS1: A Drug Target / Disease Biomarker (G100302401)

Target Name: RASAL2-AS1

NCBI ID: G100302401

RASAL2-AS1

Other Name(s): RASAL2 antisense RNA 1

RASAL2-AS1: A Drug Target / Disease Biomarker

RASAL2-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the RAS/MAPK signaling pathway, which is a well-established pathway that regulates various cellular processes in the body, including cell growth, differentiation, and survival. The RAS/MAPK pathway is a key regulator of inflammation, pain, and other cellular processes that are important for human health and disease.

Recent studies have identified RASAL2-AS1 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. RASAL2-AS1 has been shown to play a role in the development and progression of these diseases, and may be a useful target for new therapies.

One of the key functions of RASAL2-AS1 is its role in the regulation of cell signaling pathways. It is a key regulator of the RAS/MAPK pathway, which is a critical pathway that regulates various cellular processes in the body. The RAS/MAPK pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key regulator of many cellular processes that are important for human health and disease.

Studies have shown that RASAL2-AS1 plays a key role in the regulation of cell signaling pathways that are involved in cancer development. For example, studies have shown that RASAL2-AS1 is involved in the regulation of cell signaling pathways that are involved in the development and progression of cancer. This may be because RASAL2-AS1 is involved in the regulation of cell signaling pathways that are important for the growth and survival of cancer cells.

In addition to its role in the regulation of cell signaling pathways, RASAL2-AS1 has also been shown to play a key role in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. For example, studies have shown that RASAL2-AS1 is involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

RASAL2-AS1 has also been shown to play a key role in the regulation of cellular processes that are important for the development and progression of autoimmune disorders. For example, studies have shown that RASAL2-AS1 is involved in the regulation of cellular processes that are important for the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

In conclusion, RASAL2-AS1 is a protein that is involved in the regulation of various cellular processes in the body. Its role in the regulation of cell signaling pathways, cancer development, neurodegenerative diseases, and autoimmune disorders makes it a potential drug target or biomarker for these diseases. Further research is needed to fully understand the role of RASAL2-AS1 in these processes and to develop new therapies that target this protein.

Protein Name: RASAL2 Antisense RNA 1

The "RASAL2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASAL2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets